Keyphrases
Phosphoprotein
100%
Dopamine
100%
Prostate Cancer
100%
Coronary Artery Disease
95%
Hemangioblast
75%
Overexpression
69%
Neoepitope
66%
Poor Outcome
62%
SNP
58%
RNA Sequencing (RNA-seq)
56%
Metastasis
56%
Predictive Biomarker
56%
Neoantigen
54%
Tumor Cell Proliferation
50%
Epidermal Growth Factor Receptor
50%
ErbB3
50%
Lung Adenocarcinoma
50%
Molecular Targeted Therapy
50%
Small Cell Lung Cancer
50%
Cyclic Adenosine Monophosphate (cAMP)
50%
Neuroendocrine Tumor Cells
50%
AGGF1
50%
Achaete-scute Homolog 1
50%
Rs17465637
50%
MIA3
50%
Ischemic Stroke
50%
Endothelial Barrier
50%
Mouse Limb
50%
Signal Transducer and Activator of Transcription 3
50%
RNA-seq Data
50%
Meta-analysis
50%
RNA Splicing Factors
50%
Transcriptome Analysis
50%
ROBO1
50%
Vascular Development
50%
Cancer Subtypes
50%
Regulatory Axis
50%
19p13.2
50%
Single nucleotide Polymorphism
50%
Vascular Permeability
50%
Cancer Transcriptome
50%
BRG1
50%
Angiogenic Factors
50%
Limb Ischemia
50%
Myelopoiesis
50%
Aggressive Tumor
50%
Exitron
50%
Via Resistance
50%
Cancer Growth
50%
DOCK1
50%
Biochemistry, Genetics and Molecular Biology
Phosphoprotein
100%
Cyclic Adenosine Monophosphate
100%
Zebra Fish
98%
Coronary Artery Disease
91%
Angiogenesis
71%
Allele
70%
Hemangioblast
66%
Genetics
65%
Single Nucleotide Polymorphism
60%
Genome Wide Association Study
55%
Tumor Progression
54%
Targeted Therapy
53%
Indel
50%
Gene Expression Profiling
50%
Myelopoiesis
50%
RNA Splicing
50%
Hematopoiesis
50%
Vascularization
50%
RNA Sequencing
50%
Promoter Region
50%
Gene Interaction
50%
ERBB3
50%
Cell Proliferation
50%
Splicing Factor
50%
RNA Sequence
50%
Gene Expression
50%
EC50
50%
High Risk Population
50%
Single-Nucleotide Polymorphism
50%
Epidermal Growth Factor Receptor
50%
Guanosine Triphosphate
50%
Somatic Mutation
50%
Exon
50%
Catenin
50%
Major Histocompatibility Complex
50%
Proteome
50%
Intron
50%
Myeloid
50%
Atrial Fibrillation
50%
Protein Kinase B
50%
Vascular Endothelial Growth Factor
50%
Transcriptome
50%
Pan-cancer
50%
STAT3
50%
Blood Vessel Permeability
50%
Blood Flow
37%
SMARCA4
33%
Cancer Cell
28%
Genotyping
20%
Isoform
18%
